ENTITY
Dr. Lal PathLabs

Dr. Lal PathLabs (DLPL IN)

94
Analysis
Health Care • India
Dr. Lal PathLabs Limited is an Indian diagnostic and healthcare service provider, offering a comprehensive range of pathology, radiology, and cardiology tests. The company's services include routine blood and urine tests, specialized screenings for conditions like diabetes and cancer, and preventive health check-ups. Headquartered in New Delhi, India, the company was founded in 1949.
more
bullish•Cross Asset Strategy
•01 Apr 2025 17:23

The Lebaran Week That Was in ASEAN@Smartkarma - MAPI, CLEO, and Berli Jucker

The past week saw insights on Mitra Adiperkasa (MAPI IJ), Sariguna Primatirta Tbk PT (CLEO IJ), Global Digital Niaga (BELI IJ), Prodia (PRDA IJ),...

Logo
424 Views
Share
bullish•Cross Asset Strategy
•18 Mar 2025 01:50

The Week That Was in ASEAN@Smartkarma - CPALL, Arwana Citramulia, and Sido Muncul

The past week saw insights on CP ALL PCL (CPALL TB), Arwana Citramulia (ARNA IJ), Sido Muncul (SIDO IJ), and AvePoint (AVPT US)

Logo
350 Views
Share
•26 Jan 2025 08:30

APAC Healthcare Weekly (Jan 26)- Daiichi Sankyo, Sumitomo Pharma, Fosun Pharma, SK Bioscience, Hugel

APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...

Logo
560 Views
Share
•06 Jan 2025 15:50

Thematic Report: Changing Indian Pharma Landscape: Patents, USFDA, Policy Support

​India is a global pharmaceutical leader, supplying a significant portion of generic drugs and vaccines, with projections reaching $450 billion by...

Logo
568 Views
Share
•20 Oct 2024 07:30

APAC Healthcare Weekly (Oct 20)- Eisai, Daiichi Sankyo, Junshi Bioscience, Akeso, Celltrion, Neuren

This insight collates key news in APAC healthcare last week. With the earnings season beginning to unfold along with major pharma and healthcare...

Logo
610 Views
Share
x